Stay updated on LN-144 in Metastatic Melanoma Brain Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Melanoma Brain Clinical Trial page.

Latest updates to the LN-144 in Metastatic Melanoma Brain Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedAdded the Locations section with New York as a study location and updated the page to revision v3.3.3; the old 'New York Locations' label and the 'HHS Vulnerability Disclosure' link were removed.SummaryDifference0.3%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page. No study content, layout, or functionality appears to be affected.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRemoval of the funding-status banner regarding government appropriations. It previously warned that information on the site may not be up to date and that inquiries could be delayed.SummaryDifference0.4%

- Check71 days agoChange DetectedThe updated screenshot shows UI adjustments and updated posting dates. Core study details, eligibility criteria, and primary outcomes appear unchanged.SummaryDifference0.5%

- Check100 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference5%

Stay in the know with updates to LN-144 in Metastatic Melanoma Brain Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Melanoma Brain Clinical Trial page.